Monthly payouts in 2026 have run $0.102, $0.105, and $0.108, tracking close to the $0.1055 average seen across 2025. That is a meaningful step up from the $0.0865 average in 2024.
The iShares Biotechnology ETF is the default large-cap vehicle for the sector. It is market-cap weighted, which concentrates the fund in cash-generative incumbents rather than spreading capital across clinical-stage names.
Firm Treasury yields could continue to weigh on the metal amid ongoing inflation concerns. Lingering tensions in the Strait of Hormuz could continue to push oil prices up, reinforcing inflation concerns and weighing on bullion.
EMLC holds a broad mix of about 507 bonds issued by emerging market governments, all denominated in local currencies such as the Brazilian real, South African rand, Turkish lira, and Mexican peso. Almost the entire portfolio is sovereign debt at roughly 99 percent, so the fund is essentially a pure government credit exposure.
Annaly's dividend coverage is tight but intact. The company paid $0.70 per share quarterly throughout 2025, and its non-GAAP earnings available for distribution covered that payout in every quarter, ranging from $0.72 to $0.73 per share.
Occidental's operational story is strong, with Q4 2025 production hitting 1,481 thousand barrels of oil equivalent per day, exceeding guidance, and the Permian Basin setting a record at 800 Mboed in Q3 2025.
Over time, markets get ahead of themselves. Excitement over AI, green energy, or whatever the next big thing is tends to push stock valuations far beyond what fundamentals justify. Accordingly, more often than not, a correction can be the catalyst that brings valuation discipline back into the discussion. Think of it as the market taking a deep breath.
While over-diversification is not a term you hear often, the financial industry has spent decades telling investors that more is better. More funds, more sectors, more geographic exposure, and more asset classes, galore. The thing is, when a retiree holds 15 or 20 ETFs across overlapping strategies, the result isn't going to be safety, more like dilution.
We're on a rollercoaster of AI disruption with geopolitical risks adding to the uneasy ride. Sell-offs have rocked markets as artificial intelligence tools and services threaten to disrupt sectors. High geopolitical tensions have also been the theme so far this year, with the ongoing US military build‑up in the Middle East, while the assault on Venezuela and January's stand‑off over Greenland are still front of mind.
